BioAge Labs Inc.(BIOA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BIOA BioAge Labs Inc.

Post-Mkt 01-23 16:00:30 EST

18.81

-0.09

-0.48%

盘后18.81

+0.000.00%

16:00 EST

High18.96	Low18.37	Vol945.15K
Open18.75	D1 Closing18.90	Amplitude3.12%
Mkt Cap674.43M	Tradable Cap457.25M	Total Shares35.86M
T/O17.64M	T/O Rate3.89%	Tradable Shares24.31M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BIOA","market":"US","secType":"STK","nameCN":"BioAge Labs Inc.","latestPrice":18.81,"timestamp":1769201999999,"preClose":18.9,"halted":0,"volume":945150,"hourTrading":{"tag":"盘后","latestPrice":18.81,"preClose":18.81,"latestTime":"16:00 EST","volume":6098,"amount":114703.37999999999,"timestamp":1769202004561,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.0047619047619047545,"floatShares":24308899,"shares":35855037,"eps":-2.111699,"marketStatus":"Post-Mkt","change":-0.09,"latestTime":"01-23 16:00:30 EST","open":18.75,"high":18.96,"low":18.37,"amount":17642191.63845,"amplitude":0.031217,"askPrice":18.94,"askSize":105,"bidPrice":18.49,"bidSize":1,"shortable":3,"etf":0,"ttmEps":-2.111699,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1769216400000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1727323200000,"exchange":"NASDAQ","adjPreClose":18.9,"preHourTrading":{"tag":"盘前","latestPrice":18.52,"preClose":18.9,"latestTime":"08:52 EST","volume":4648,"amount":87836.611856,"timestamp":1769176336284,"change":-0.38,"changeRate":-0.020106,"amplitude":0.020106},"postHourTrading":{"tag":"盘后","latestPrice":18.81,"preClose":18.81,"latestTime":"16:00 EST","volume":6098,"amount":114703.37999999999,"timestamp":1769202004561,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.754818,"impliedVol":0.5796,"impliedVolPercentile":0.3109},"requestUrl":"/m/hq/s/BIOA/tweets","defaultTab":"tweets","newsList":[{"id":"2605385411","title":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, JPMorgan, Intel","url":"https://stock-news.laohu8.com/highlight/detail?id=2605385411","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605385411?lang=en_us&edition=fundamental","pubTime":"2026-01-23 02:42","pubTimestamp":1769107366,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Tesla, JPMorgan, IntelEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter: https://ref","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nL6N3YN0S2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NEXT","CTSH","JANX","GGLS","CRVS","GLSI","NFE","SCCO","INTC","ACI","HBAN","CBSH","RMBS","TSLR","CAL","BIOA","TDY","NEM","ACMR","KMI","WINA","PSKY","CORT","VG","TSLA","MULL","JPM","LRCX","MDCX","MUD","MKC","ORI","ABT","PG","PSQH","ADSK","ELAN","GE","CRSH","TCBK","LTH","WYFI","DDOG","GGLL"],"gpt_icon":1},{"id":"2605492696","title":"BUZZ-U.S. STOCKS ON THE MOVE- Medicus Pharma, Lam Research, Applied Digital","url":"https://stock-news.laohu8.com/highlight/detail?id=2605492696","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605492696?lang=en_us&edition=fundamental","pubTime":"2026-01-22 22:11","pubTimestamp":1769091106,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Medicus Pharma, Lam Research, Applied DigitalEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nL6N3YN0S4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MULL","GB00BDT5M118.USD","ABT","LTH","BIOA","LU2152927971.USD","LU0545039389.USD","89988","MDCX","CORT","CTSH","HBBD.SI","LU2129689605.HKD","LU0231203729.USD","LU3063872942.SGD","LU0640476718.USD","GLSI","CRVS","LU2129689514.USD","APLD","IE00B5MMRT66.SGD","CAL","HBAN","LU0561508036.HKD","LU0708995153.HKD","MUD","BTBT","ELAN","LU2778985437.USD","BK1249","RMBS","WYFI","KMI","VG","JANX","GE","LU0052750758.USD","89888","ALBmain","LU0315178854.USD","LU0516423174.USD","PG","BMY","LRCX"],"gpt_icon":1},{"id":"2605494832","title":"BUZZ-BioAge Labs edges down after stock sale hiked to $115 mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2605494832","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605494832?lang=en_us&edition=fundamental","pubTime":"2026-01-22 21:34","pubTimestamp":1769088858,"startTime":"0","endTime":"0","summary":"** BioAge Labs BIOA.O shares down 0.3% before the bell at $20.06 after co raises more equity than planned. ** Emeryville, California-based biopharma late Weds sold ~5.9 mln shares, about 16% of total outstanding, at $19.50 for $115 mln gross proceeds. ** Offering price represents 3.1% discount to stock's last close. ** BIOA shares on Weds finished down 5.6% after co late Tues unveiled $75 mln offering. Co intends to use net offering proceeds to fund research, clinical development and manufacturing of its product candidates, including lead candidate BGE-102, a small-molecule NLRP3 inhibitor being developed for cardiovascular risk and retinal diseases, among other purposes. ** Goldman Sachs, Piper Sandler and Citigroup joint bookrunners. ** Through Weds, BIOA shares up 52% to begin 2026 and have more than tripled over the past three months. ** 1 analyst rates the stock \"strong buy\", 3 rate \"hold\"; PTs are $9, $12 and $15, per LSEG data","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nL6N3YN0WK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2471134796.USD","BK4533","BK4516","BK4585","LU0251131958.USD","BK4127","LU2471134523.USD","LU0648001328.SGD","BK4534","BK4007","LU1201861249.SGD","LU2471134879.HKD","PIPR","IE00BSNM7G36.USD","LU0096364046.USD","LU2360032135.SGD","LU2750360641.GBP","LU1894683264.USD","IE00B19Z3581.USD","LU1244550494.USD","LU2236285917.USD","BK4207","LU0130102774.USD","LU0162691827.USD","BIOA","LU0052756011.USD","LU0098860793.USD","LU1244550221.USD","LU2237443465.HKD","LU2456880835.USD","LU0980610538.SGD","IE0034235188.USD","IE00B19Z3B42.SGD","BK4504","LU2471134952.CNY","LU0128525689.USD","LU0072461881.USD","LU1804176565.USD","LU0251142724.SGD","LU0320765646.SGD","LU0130517989.USD","LU1668664300.SGD","LU0061475181.USD","IE0004091025.USD","BK4566","LU2125154778.USD","LU2417539215.USD","IE0002270589.USD","LU2237438978.USD","LU2462157665.USD"],"gpt_icon":0},{"id":"2605521456","title":"BRIEF-Bioage Announces Pricing Of Upsized $115 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2605521456","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605521456?lang=en_us&edition=fundamental","pubTime":"2026-01-22 11:30","pubTimestamp":1769052621,"startTime":"0","endTime":"0","summary":"BRIEF-Bioage Announces Pricing Of Upsized $115 Million Public OfferingJan 21 (Reuters) - BIOAGE Labs Inc BIOA.O:BIOAGE ANNOUNCES PRICING OF UPSIZED $115.0 MILLION PUBLIC OFFERINGBIOAGE LABS INC - PRIC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nTUABPRHRH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2605563414","title":"Bioage Announces Pricing of Upsized $115.0 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2605563414","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605563414?lang=en_us&edition=fundamental","pubTime":"2026-01-22 11:30","pubTimestamp":1769052600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260122:nTUABPRHRH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2605867214","title":"BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers Companies","url":"https://stock-news.laohu8.com/highlight/detail?id=2605867214","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605867214?lang=en_us&edition=fundamental","pubTime":"2026-01-21 23:49","pubTimestamp":1769010597,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Aligos, Intel, Travelers CompaniesEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsletter:","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nL6N3YM11M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2430703095.HKD","OCGN","KHC","NEM","CDE","ALB","AVR","GM","DXC","IE00B29SXL02.USD","TDY","NNE","BIOA","LBRT","LSTA","WMB","BK4534","SCHW","F","LNG","IE00BBT3K403.USD","LUCD","AMBQ","SLB","TRV","EXE","CNX","LU0154245673.USD","UAL","PLD","LPTH","BK4141","TFC","BKR","HL","INTC","NATH","IE00B775SV38.USD","CBIO","ROCK","BK4533","OCUL","ALGS","LXRX","HAL","LU0985481810.HKD","JNJ"],"gpt_icon":1},{"id":"2605483858","title":"BUZZ-U.S. STOCKS ON THE MOVE-Teledyne, Arm Holdings, Nathan’s Famous","url":"https://stock-news.laohu8.com/highlight/detail?id=2605483858","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605483858?lang=en_us&edition=fundamental","pubTime":"2026-01-21 22:25","pubTimestamp":1769005524,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Teledyne, Arm Holdings, Nathan’s FamousEikon search string for individual stock moves: STXBZThe Day Ahead newsletter: https://refini.tv/3LI4BU7The Morning News Call newsle","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260121:nL6N3YM0P9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HL","PAVM","RIO.UK","IE00BLSP4452.SGD","LU1023059063.AUD","CBIO","ARM","LU0417517546.SGD","PLD","NEM","IE0004091025.USD","NATH","LXRX","JNJ","LUCD","RIO.AU","LU1201861165.SGD","FCX","LPTH","TRV","LU2362540622.SGD","LBRT","AVR","LU0347712357.USD","TEL","SG9999002224.SGD","TFC","HAL","CDE","SG9999002232.USD","SLB","ROCK","NFLX","UAL","BK4145","LU1066051811.HKD","BIOA","LU2272731782.SGD","TDY","LU0130103400.USD","OCUL","LU0079474960.USD","KHC","LU2272731600.USD","SCHW","BHP.AU","ALB","LU2463526074.USD","BKR"],"gpt_icon":0},{"id":"2605934140","title":"BioAge Labs: Early-Stage Promise for BGE-102 Balanced by Long Timelines and Clinical Risk, Justifying Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2605934140","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605934140?lang=en_us&edition=fundamental","pubTime":"2026-01-21 07:56","pubTimestamp":1768953391,"startTime":"0","endTime":"0","summary":"Analyst Michael Ulz from Morgan Stanley maintained a Hold rating on BioAge Labs, Inc. and keeping the price target at $12.00. Michael Ulz has given...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/bioage-labs-early-stage-promise-for-bge-102-balanced-by-long-timelines-and-clinical-risk-justifying-hold-rating-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/bioage-labs-early-stage-promise-for-bge-102-balanced-by-long-timelines-and-clinical-risk-justifying-hold-rating-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","SSI"],"gpt_icon":0},{"id":"2605142175","title":"BioAge Labs Proposes Public Offering Worth $75 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2605142175","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605142175?lang=en_us&edition=fundamental","pubTime":"2026-01-21 06:30","pubTimestamp":1768948207,"startTime":"0","endTime":"0","summary":"BioAge Labs (BIOA) reported late Tuesday that it plans to launch a public offering of up to $75 million of common shares.Underwriters will be given a 30-day option to buy an additional $11.3 million o","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2605385141","title":"BioAge Labs announces $75M common stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2605385141","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605385141?lang=en_us&edition=fundamental","pubTime":"2026-01-21 05:11","pubTimestamp":1768943482,"startTime":"0","endTime":"0","summary":"BioAge Labs (BIOA) announced a proposed underwritten public offering in which it intends to offer and sell, subject to market and other conditions,...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-announces-75m-common-stock-offering-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-announces-75m-common-stock-offering-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2605496391","title":"Bioage Labs Inc - to Offer up to $75 Mln of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2605496391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605496391?lang=en_us&edition=fundamental","pubTime":"2026-01-21 05:01","pubTimestamp":1768942860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA2CDQZH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2605114966","title":"Bioage Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2605114966","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605114966?lang=en_us&edition=fundamental","pubTime":"2026-01-21 05:01","pubTimestamp":1768942860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA2CDQZH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2605146597","title":"BioAge Labs management to meet with Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2605146597","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605146597?lang=en_us&edition=fundamental","pubTime":"2026-01-21 03:55","pubTimestamp":1768938919,"startTime":"0","endTime":"0","summary":"Meeting to be held in Boston on January 28 hosted by Piper Sandler. Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-management-to-meet-with-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-management-to-meet-with-piper-sandler-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2605145355","title":"BioAge Labs: Early-Stage NLRP3 Opportunity in Ophthalmology and Cardiometabolic Disease Warrants Neutral ‘Hold’ Amid Long Clinical Timelines","url":"https://stock-news.laohu8.com/highlight/detail?id=2605145355","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605145355?lang=en_us&edition=fundamental","pubTime":"2026-01-21 02:55","pubTimestamp":1768935350,"startTime":"0","endTime":"0","summary":"William Blair analyst Andy Hsieh has reiterated their neutral stance on BIOA stock, giving a Hold rating yesterday. Andy Hsieh has given his Hold r...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/bioage-labs-early-stage-nlrp3-opportunity-in-ophthalmology-and-cardiometabolic-disease-warrants-neutral-hold-amid-long-clinical-timelines-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/bioage-labs-early-stage-nlrp3-opportunity-in-ophthalmology-and-cardiometabolic-disease-warrants-neutral-hold-amid-long-clinical-timelines-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SSI","BIOA"],"gpt_icon":0},{"id":"2604119238","title":"BioAge Labs announces expansion of its BGE-102 development program","url":"https://stock-news.laohu8.com/highlight/detail?id=2604119238","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604119238?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:16","pubTimestamp":1768918585,"startTime":"0","endTime":"0","summary":"BioAge Labs (BIOA) announced expansion of its BGE-102 development program into ophthalmology, with an initial proof-of-concept, POC, study in patie...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/bioage-labs-announces-expansion-of-its-bge-102-development-program-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/bioage-labs-announces-expansion-of-its-bge-102-development-program-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2604119826","title":"BioAge Labs Expands BGE-102 Program to Diabetic Macular Edema with Oral NLRP3 Inhibitor","url":"https://stock-news.laohu8.com/highlight/detail?id=2604119826","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604119826?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:01","pubTimestamp":1768917665,"startTime":"0","endTime":"0","summary":"BioAge Labs Inc. has announced the planned expansion of its BGE-102 development program into ophthalmology, with a focus on diabetic macular edema . BGE-102, an orally administered NLRP3 inhibitor, has shown favorable tolerability and significant reductions in inflammatory biomarkers such as hsCRP, IL-6, and IL-1β in an ongoing Phase 1 trial. The company will initiate a Phase 1b/2a proof-of-concept clinical trial in DME patients in mid-2026, aiming to demonstrate ocular target engagement. The primary endpoint of the upcoming trial will be the percent change in intraocular IL-6, with results expected in mid-2027. These results have not yet been presented and are anticipated in the future.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. B","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nNDL1BHjyD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","BK4588","BK4112","IE00B3QW5Z07.USD","LU0314104364.USD","LU2095319765.USD","NDAQ","SG9999014039.USD","BK4007","SG9999014021.USD","LU2210150020.SGD","LU2210149790.SGD","SG9999014013.SGD","BK4585","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","BIOA"],"gpt_icon":0},{"id":"2604195241","title":"Bioage Labs Inc - Dme Trial Results Expected Mid-2027, Bge-102 Phase 2a Cardiovascular Trial Results Anticipated in 2H26","url":"https://stock-news.laohu8.com/highlight/detail?id=2604195241","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604195241?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:00","pubTimestamp":1768917606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA3VMC1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2604160711","title":"Bioage Announces Indication Expansion for Oral Nlrp3 Inhibitor Bge-102, With Plans to Initiate Phase 1B/2a Proof-of-Concept Clinical Trial in Patients With Diabetic Macular Edema in Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2604160711","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604160711?lang=en_us&edition=fundamental","pubTime":"2026-01-20 22:00","pubTimestamp":1768917606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260120:nTUA3VMC1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BIOA","BK4007"],"gpt_icon":0},{"id":"2603293521","title":"BioAge Labs CEO Kristen Fortney Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2603293521","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603293521?lang=en_us&edition=fundamental","pubTime":"2026-01-16 05:20","pubTimestamp":1768512051,"startTime":"0","endTime":"0","summary":"Kristen Fortney, Chief Executive Officer of BioAge Labs Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bioage Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 15, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260115:nNDL3K4F6h:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"BioAge Labs CEO Kristen Fortney Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BIOA"],"gpt_icon":0},{"id":"2603683119","title":"BioAge Labs, Inc. (BIOA) Gets a Buy from Citi","url":"https://stock-news.laohu8.com/highlight/detail?id=2603683119","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603683119?lang=en_us&edition=fundamental","pubTime":"2026-01-13 19:17","pubTimestamp":1768303023,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Samantha Semenkow from Citi reiterated a Buy rating on BioAge Labs, Inc., with a price target of $15.00. The compan...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/bioage-labs-inc-bioa-gets-a-buy-from-citi-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/bioage-labs-inc-bioa-gets-a-buy-from-citi-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BIOA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://bioagelabs.com","stockEarnings":[{"period":"1week","weight":-0.1213},{"period":"1month","weight":0.4307},{"period":"3month","weight":1.4868},{"period":"6month","weight":3.0909},{"period":"1year","weight":2.6986},{"period":"ytd","weight":0.4286}],"compareEarnings":[{"period":"1week","weight":-0.0047},{"period":"1month","weight":0.0015},{"period":"3month","weight":0.0173},{"period":"6month","weight":0.0814},{"period":"1year","weight":0.1361},{"period":"ytd","weight":0.0104}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":" ","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.008123},{"month":2,"riseRate":0.4,"avgChangeRate":-0.16094},{"month":3,"riseRate":0.2,"avgChangeRate":-0.091972},{"month":4,"riseRate":0.4,"avgChangeRate":-0.044244},{"month":5,"riseRate":0,"avgChangeRate":-0.19738},{"month":6,"riseRate":0.25,"avgChangeRate":0.003055},{"month":7,"riseRate":0.4,"avgChangeRate":-0.005696},{"month":8,"riseRate":0.4,"avgChangeRate":-0.229124},{"month":9,"riseRate":0.6,"avgChangeRate":0.004924},{"month":10,"riseRate":0.8,"avgChangeRate":0.181962},{"month":11,"riseRate":0.6,"avgChangeRate":0.056827},{"month":12,"riseRate":0.2,"avgChangeRate":-0.087267}],"exchange":"NASDAQ","name":"BioAge Labs Inc.","nameEN":"BioAge Labs Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"BioAge Labs Inc.(BIOA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest BioAge Labs Inc.(BIOA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"BioAge Labs Inc.,BIOA,BioAge Labs Inc.股票,BioAge Labs Inc.股票老虎,BioAge Labs Inc.股票老虎国际,BioAge Labs Inc.行情,BioAge Labs Inc.股票行情,BioAge Labs Inc.股价,BioAge Labs Inc.股市,BioAge Labs Inc.股票价格,BioAge Labs Inc.股票交易,BioAge Labs Inc.股票购买,BioAge Labs Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"BioAge Labs Inc.(BIOA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest BioAge Labs Inc.(BIOA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}